Pacific Capital Partners Ltd Makes New $1.08 Million Investment in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Key Points

• Pacific Capital Partners Ltd has acquired a new stake in Prestige Consumer Healthcare Inc. during the first quarter, purchasing 12,500 shares valued at approximately $1,075,000.
• Several hedge funds have also adjusted their positions in Prestige Consumer Healthcare, with institutional investors owning nearly 99.95% of the company's stock.
• Analysts have given Prestige Consumer Healthcare a consensus rating of "Moderate Buy" with a target price of $93.33, indicating positive growth expectations for the stock.

Pacific Capital Partners Ltd purchased a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 12,500 shares of the company's stock, valued at approximately $1,075,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. XTX Topco Ltd increased its position in Prestige Consumer Healthcare by 354.0% in the first quarter. XTX Topco Ltd now owns 22,778 shares of the company's stock worth $1,958,000 after purchasing an additional 17,761 shares during the period. Texas Yale Capital Corp. grew its position in shares of Prestige Consumer Healthcare by 22.7% during the 1st quarter. Texas Yale Capital Corp. now owns 7,239 shares of the company's stock worth $622,000 after buying an additional 1,339 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Prestige Consumer Healthcare by 11.3% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,304 shares of the company's stock worth $1,058,000 after buying an additional 1,251 shares during the last quarter. Diversify Advisory Services LLC boosted its stake in Prestige Consumer Healthcare by 29.9% in the first quarter. Diversify Advisory Services LLC now owns 4,364 shares of the company's stock valued at $358,000 after acquiring an additional 1,004 shares during the last quarter. Finally, Diversify Wealth Management LLC raised its position in shares of Prestige Consumer Healthcare by 24.3% during the 1st quarter. Diversify Wealth Management LLC now owns 12,929 shares of the company's stock valued at $1,059,000 after acquiring an additional 2,530 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Stock Down 0.3%

PBH stock traded down $0.22 during mid-day trading on Friday, hitting $73.73. 423,917 shares of the company were exchanged, compared to its average volume of 367,855. The firm has a market cap of $3.64 billion, a P/E ratio of 17.19, a P/E/G ratio of 2.25 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a 1-year low of $64.94 and a 1-year high of $90.04. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.82 and a current ratio of 4.20. The firm's 50 day simple moving average is $80.89 and its 200 day simple moving average is $82.28.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping analysts' consensus estimates of $1.30 by $0.02. The firm had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The company's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the prior year, the business earned $1.02 EPS. On average, sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on PBH shares. Wall Street Zen raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Royal Bank Of Canada raised Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, Prestige Consumer Healthcare presently has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.